Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-029715
Filing Date
2010-05-27
Accepted
2010-05-27 12:59:55
Documents
1
Period of Report
2010-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd277061.html 3  
1 FORM 3 rrd277061.xml 3 2142
  Complete submission text file 0001181431-10-029715.txt   4328
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Reporting) CIK: 0001003124 (see all company filings)

State of Incorp.: NC | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34641 | Film No.: 10861682
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-380-2000
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations